deficiency
arginine
esterase
cystic
fibrosis
pancreas
demonstration
proteolytic
nature
activity
proteolytic
activity
defined
hydrolysis
peptide
bonds
involving
carboxyl
group
l
arginine
plasma
patients
cystic
fibrosis
heterozygotes
control
subjects
assayed
using
fluorometric
method
protamine
substrate
fluorescamine
reagent
mean
total
proteolytic
activity
plasma
patients
cystic
fibrosis
approximately
one
half
mean
total
activity
control
subjects
heterozygotes
mean
proteolytic
activity
inhibited
soybean
trypsin
inhibitor
plasma
patients
cystic
fibrosis
approximately
one
third
control
subjects
heterozygotes
relationship
arginine
esterase
activity
proteolytic
activity
investigated
ph
optimum
action
reversible
irreversible
inhibitors
similar
activities
suggesting
arginine
esterase
activity
proteolytic
activity
represent
similar
catalytic
entities
findings
consistent
hypothesis
basic
defect
cystic
fibrosis
may
reside
deficiency
proteolytic
enzyme
results
accumulation
various
cationic
macromolecular
factors
described
investigators
serum
patients
cystic
fibrosis
demonstration
deficiency
proteolytic
activity
assayed
hydrolysis
protamine
cationic
polypeptide
could
explain
presence
ciliotoxic
cationic
protein
polypeptide
factors
serum
patients
cystic
fibrosis
may
unknown
manner
related
clinical
manifestations
disease
